Med-Fine Capital

Med-Fine Capital operates as a specialized venture capital firm dedicated to investment within the healthcare and life sciences sectors. The firm focuses on identifying and supporting early-stage innovation across China's dynamic medical landscape. It distinguishes itself by actively seeking opportunities to co-found new ventures alongside serial entrepreneurs, meticulously selecting highly promising strategic directions and assets for its portfolio companies.

The firm was founded in 2014 by Jack Zhou, leveraging an understanding of the burgeoning healthcare market in China. Zhou established Med-Fine Capital to address the critical need for specialized capital and strategic guidance for nascent companies in the biotech and broader life sciences fields. The firm’s management team brings a significant combination of deep healthcare industry insight and extensive venture capital experience to its investment approach.

Med-Fine Capital primarily serves early-stage healthcare and life science companies seeking both financial backing and strategic partnership to develop and scale their innovations. The company's long-term vision is centered on advancing global innovation through its support of the Chinese biotech and healthcare ecosystem. It aims to foster the development of transformative medical solutions, thereby shaping the future of health.